Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)

Name: Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
License: Public Domain

Shanghai Zhongshan Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric / gastroesophageal junction adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261506
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.